Results 1 to 10 of about 6,129,228 (249)

The mainz resilience assessment in childhood cancer (MRAcc): development of a novel age-specific patient-reported outcome measure to assess resilience in childhood cancer patients [PDF]

BMC Cancer
Background During intensive cancer treatment, children, adolescents and young adults are exposed to numerous toxicities and psychosocial stressors that can cause psychosocial distress and impair mental health.
Marie A. Neu, Franziska Ortmüller, Abigale L. Robinson, Elias Dreismickenbecker, Henrike Otto, Lena Wypyrsczyk, Mareike Kühn, Michèle Wessa, Oliver Tüscher, Joerg Faber, on behalf of the FORTEe Consortium   +10 more
doaj   +2 more sources

Childhood and adolescent cancer in Germany – an overview [PDF]

Journal of Health Monitoring, 2023
Background: Childhood and adolescent cancer constitutes only a very small fraction of the cancer cases in Germany and throughout the world, but it is the most frequent cause of disease-related death in children.
Claudia Spix, Friederike Erdmann, Desiree Grabow, Cécile Ronckers   +3 more
doaj   +1 more source

Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort.

The Lancet, 2023
BACKGROUND 5-year survival after childhood cancer does not fully describe life-years lost due to childhood cancer because there are a large number of deaths occurring beyond 5-years (late mortality) related to cancer and cancer treatment. Specific causes
S. Dixon, Qi Liu, E. Chow, K. Oeffinger, P. Nathan, R. Howell, W. Leisenring, M. Ehrhardt, K. Ness, K. Krull, A. Mertens, M. Hudson, L. Robison, Y. Yasui, G. Armstrong   +14 more
semanticscholar   +1 more source

Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.

The Lancet Oncology, 2021
Female patients with childhood, adolescent, and young adult cancer are at increased risk for fertility impairment when treatment adversely affects the function of reproductive organs. Patients and their families desire biological children but substantial
R. Mulder, A. Font‐Gonzalez, M. Hudson, H. V. van Santen, E. Loeffen, K. Burns, G. Quinn, E. van Dulmen-den Broeder, J. Byrne, R. Haupt, W. Wallace, M. M. van den Heuvel-Eibrink, A. Anazodo, R. Anderson, Anke Barnbrock, J. Beck, A. Bos, I. Demeestere, C. Denzer, N. Di Iorgi, Holly R Hoefgen, R. Kebudi, C. Lambalk, T. Langer, L. Meacham, K. Rodriguez-Wallberg, C. Stern, E. Stutz-Grunder, W. van Dorp, M. Veening, S. Veldkamp, Eline van der Meulen, L. Constine, Lisa B Kenney, M. D. van de Wetering, L. Kremer, Jennifer M. Levine, W. Tissing, C. Berger, T. Diesch, U. Dirksen, J. Ginsberg, A. Giwercman, D. Grabow, C. Gracia, Sarah E Hunter, Julia Inthorn, P. Kaatsch, J. Kelvin, J. Klosky, J. Laven, B. Lockart, S. Neggers, N. Paul, Michelle Peate, Bob Phillips, D. Reed, E. M. Tinner, M. H. van den Berg, C. Verhaak   +59 more
semanticscholar   +1 more source

Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.

The Lancet Oncology, 2021
Male patients with childhood, adolescent, and young adult cancer are at an increased risk for infertility if their treatment adversely affects reproductive organ function. Future fertility is a primary concern of patients and their families.
R. Mulder, A. Font‐Gonzalez, D. Green, E. Loeffen, M. Hudson, J. Loonen, R. Yu, J. Ginsberg, R. Mitchell, J. Byrne, R. Skinner, A. Anazodo, L. Constine, A. D. de Vries, K. Jahnukainen, A. Lorenzo, A. Meissner, L. Nahata, M. Dinkelman-Smit, H. Tournaye, R. Haupt, M. M. van den Heuvel-Eibrink, H. V. van Santen, A. V. van Pelt, U. Dirksen, J. den Hartogh, E. van Dulmen-den Broeder, W. Wallace, Jennifer M. Levine, W. Tissing, L. Kremer, Lisa B Kenney, M. D. van de Wetering, C. Berger, T. Diesch, A. Giwercman, D. Grabow, C. Gracia, S. Hunter, Julia Inthorn, P. Kaatsch, J. Kelvin, J. Klosky, J. Laven, B. Lockart, S. Neggers, N. Paul, Michelle Peate, Bob Phillips, G. Quinn, D. Reed, E. M. Tinner, M. H. van den Berg, C. Verhaak   +53 more
semanticscholar   +1 more source

Determinants of delayed childhood cancer care in low‐ and middle‐income countries: A systematic review

Pediatric Blood & Cancer, 2022
Early access to care is essential to improve survival rates for childhood cancer. This study evaluates the determinants of delays in childhood cancer care in low‐ and middle‐income countries (LMICs) through a systematic review of the literature.
C. Cotache-Condor, Vinootna Kantety, A. Grimm, Jahsarah Williamson, Kelsey R Landrum, K. Schroeder, C. Staton, E. Majaliwa, Shenglan Tang, Henry E Rice, Emily R. Smith   +10 more
semanticscholar   +1 more source

Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies

Cancers, 2021
Simple Summary Childhood cancers are mostly of unknown etiology and represent devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival rates are countered by severe and fatal health consequences from genotoxic ...
S. Zahnreich, H. Schmidberger
semanticscholar   +1 more source

Employment, occupation, and income in adults with neurofibromatosis 1 in Denmark: a population- and register-based cohort study

Orphanet Journal of Rare Diseases, 2023
Background Little is known about employment status, occupation, and disposable income in adults with NF1. Methods From the Danish National Patient Registry and database of two national Centers for Rare Diseases, we identified 1469 adults with NF1, who ...
Line Kenborg, Line E. Frederiksen, Michael Galanakis, Karoline Doser, Thomas T. Nielsen, Mia Aagaard Doherty, Hanne Hove, John R. Østergaard, Mette M. Handrup, Cecilie Ejerskov, John J. Mulvihill, Jeanette F. Winther   +11 more
doaj   +1 more source

Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

Cancer Cell International, 2023
Background Outcomes for patients with relapsed acute lymphoblastic leukemia (ALL) are poor and there is a need for novel therapies to improve outcomes.
Hayden L. Bell, Helen J. Blair, Mankaran Singh, Anthony V. Moorman, Olaf Heidenreich, Frederik W. van Delft, John Lunec, Julie A. E. Irving   +7 more
doaj   +1 more source

Pesticides and Childhood Cancers [PDF]

Environmental Health Perspectives, 1997
To evaluate the possible association between pesticides and the risk of childhood cancers, epidemiologic studies published between 1970 and 1996 were critically reviewed. Thirty-one studies investigated whether occupational or residential exposure to pesticides by either parents or children was related to increased risk of childhood cancer. In general,
J L, Daniels, A F, Olshan, D A, Savitz
openaire   +2 more sources